HMGB1 and neoplasm: Liu, Yang et al. demonstrated that chemotherapeutic drugs (vincristine and doxorubicin) induced human leukemia cells to release HMGB1, and activated autophagy through the PI3KC3/MEK/ERK signaling pathway to remove abnormal proteins, organelles, or ROS, in order to promote the drug resistance of tumor cells [156,158].